Kiwi cervical cancer screening device company TruScreen will look to raise cash from its shareholders yet again after posting a $1.36 million loss in the six months ended September 30.
But the business claims its key China business is growing strongly and has also today announced a $300,000 purchase
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
